The UGT1A1*28 and intronic UGT1A1*6 (rs4148323) alleles increased the likelihood of neutropenia among Asian patients treated with the anticancer drug irinotecan, compared to the wild-type UGT1A1*1 allele [76]. The gene discussed is UGT1A1; the disease is neutropenia.